http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
-
Advaxis (ADXS) Issues Business Outlook for 2016; Will Continue Pursing Immunotherapy Partnerships
-
Advaxis Provides 2016 Business Outlook
-
Advaxis Announces Filing for USDA Product License
-
Advaxis's Cancer Immunotherapy Featured on CBS News
-
Advaxis's ADXS-cHER2 Immunotherapy Continues to Demonstrate Significantly Prolonged Survival in Canine Osteosarcoma
-
Advaxis to Initiate Clinical Development of ADXS-cHER2 Immunotherapy to Treat Pediatric Bone Cancer
-
Advaxis Discusses Global Licensing Agreement for Pet Therapeutics on Conference Call

